Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Cefiderocol in Critically Ill Patients on ECMO
NCT04995835Phase 1Completed
- Sponsor
- Joseph L. Kuti
- Start
- Jul 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cefiderocol in sepsis, sponsored by Joseph L. Kuti. Primary endpoint: Cefiderocol Clearance at 8 hours. Started Jul 2021; status: completed.
02
Drugs
cefiderocol
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04995835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04995835.